Gene · 5169
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant alteration of peripheral B lymphocyte subsets in hepatocellular carcinoma patients. | Int J Med Sci | 2023 | 36794164 | PubTator, text mining | PubMed |
| Plant-based enveloped Ara h 2 bioparticles display exceptional hypo-allergenicity. | Clin Exp Allergy | 2023 | 36779573 | PubTator, text mining | PubMed |
| Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs. | Molecules | 2023 | 36770990 | PubTator, text mining | PubMed |
| Effect of Simulated Mastication on Structural Stability of Prosthetic Zirconia Material after Thermocycling Aging. | Materials (Basel) | 2023 | 36770181 | PubTator, text mining | PubMed |
| 4-Methylumbelliferone Targets Revealed by Public Data Analysis and Liver Transcriptome Sequencing. | Int J Mol Sci | 2023 | 36768453 | PubTator, text mining | PubMed |
| MATHEMATICAL MODELLING APPROACH OF THE STUDY OF EBOLA VIRUS DISEASE TRANSMISSION DYNAMICS IN A DEVELOPING COUNTRY. | Afr J Infect Dis | 2023 | 36756492 | PubTator, text mining | PubMed |
| Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities. | Oncologist | 2023 | 36745503 | PubTator, text mining | PubMed |
| Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria. | Cell | 2023 | 36736301 | PubTator, text mining | PubMed |
| Human ILC1s target leukemia stem cells and control development of AML. | Res Sq | 2023 | 36711868 | PubTator, text mining | PubMed |
| A membrane reticulum, the centriculum, affects centrosome size and function in Caenorhabditis elegans. | Curr Biol | 2023 | 36693370 | PubTator, text mining | PubMed |
| Design, Synthesis, anticancer evaluation and in silico studies of 2,4,6-trimethoxychalcone derivatives. | Saudi Pharm J | 2023 | 36685294 | PubTator, text mining | PubMed |
| Development of nucleocapsid-specific monoclonal antibodies for SARS-CoV-2 and their ELISA diagnostics on an automatic microfluidic device. | Sens Actuators B Chem | 2023 | 36644652 | PubTator, text mining | PubMed |
| Bioinformatics analysis of key biomarkers for bladder cancer. | Biomed Rep | 2023 | 36643693 | PubTator, text mining | PubMed |
| Effects of industrially produced 2-dimensional molybdenum disulfide materials in primary human basophils. | NanoImpact | 2023 | 36626980 | PubTator, text mining | PubMed |
Accuracy and efficiency of an artificial intelligence-based pulmonary broncho-vascular three-dimensional reconstruction system supporting thoracic surgery: retrospective and prospective validation study. | EBioMedicine | 2023 | 36565503 | PubTator, text mining | PubMed |
| Human septins organize as octamer-based filaments and mediate actin-membrane anchoring in cells. | J Cell Biol | 2023 | 36562751 | PubTator, text mining | PubMed |
| Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group. | Cytometry B Clin Cytom | 2023 | 36537621 | PubTator, text mining | PubMed |
| Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study. | Allergy | 2023 | 36478407 | PubTator, text mining | PubMed |
| What happens to basophils and tryptase, LXA4 and CysLTs during aspirin desensitization? | J Asthma | 2023 | 36472920 | PubTator, text mining | PubMed |
| Design and synthesis of new adamantyl derivatives as promising antiproliferative agents. | Eur J Med Chem | 2023 | 36470105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5169/papers?page=13